Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB
- 21 December 2020
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 59 (3), 243-247
- https://doi.org/10.1136/jmedgenet-2020-107286
Abstract
Background SNP-based polygenic risk scores have recently been adopted in the clinic for risk assessment of some common diseases. Their validity is supported by a consistent trend between their percentile rank and disease risk in populations. However, for clinical use at the individual level, the reliability of score values is necessary considering they are directly used to calculate remaining lifetime risk. Objectives We assessed the reliability of polygenic score values to estimate prostate cancer (PCa), breast cancer (BCa) and colorectal cancer (CRC) risk in three incident cohorts from the UK Biobank (n>500 000). Methods Cancer-specific Genetic Risk Score (GRS), a well-established population-standardised polygenic risk score, was calculated. Results A systematic bias was found between estimated risks (GRS values) and observed risks; β (95% CI) was 0.67 (0.58–0.76), 0.74 (0.65–0.84) and 0.82 (0.75–0.89), respectively, for PCa, BCa and CRC, all significantly lower than 1.00 (perfect calibration), pConclusion Assessing the calibration of polygenic risk scores is necessary and feasible to ensure their reliability prior to clinical implementation.Keywords
This publication has 13 references indexed in Scilit:
- Concept and benchmarks for assessing narrow‐sense validity of genetic risk score valuesThe Prostate, 2019
- The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019Nucleic Acids Research, 2018
- The UK Biobank resource with deep phenotyping and genomic dataNature, 2018
- Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutationsNature Genetics, 2018
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociNature Genetics, 2018
- Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General PopulationAmerican Journal of Epidemiology, 2017
- Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard scorePLoS Medicine, 2017
- Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian RandomizationJNCI Journal of the National Cancer Institute, 2015
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic VariantsJNCI Journal of the National Cancer Institute, 2015
- Overcoming the Winner’s Curse: Estimating Penetrance Parameters from Case-Control DataAmerican Journal of Human Genetics, 2007